Europe Radiation Oncology Market Size & Outlook, 2020-2028

The radiation oncology market in Europe is expected to reach a projected revenue of US$ 3,607.7 million by 2028. A compound annual growth rate of 7.6% is expected of Europe radiation oncology market from 2021 to 2028.
Revenue, 2020 (US$M)
$2,006.1
Forecast, 2028 (US$M)
$3,607.7
CAGR, 2021 - 2028
7.6%
Report Coverage
Europe

Europe radiation oncology market highlights

  • The Europe radiation oncology market generated a revenue of USD 2,006.1 million in 2020.
  • The market is expected to grow at a CAGR of 7.6% from 2021 to 2028.
  • In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
  • Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2021 to 2028.


Europe data book summary

Market revenue in 2020USD 2,006.1 million
Market revenue in 2028USD 3,607.7 million
Growth rate7.6% (CAGR from 2020 to 2028)
Largest segmentExternal beam radiationtherapy
Fastest growing segmentInternal Beam Radiation Therapy
Historical data covered2017 - 2019
Base year for estimation2020
Forecast period covered2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationExternal Beam RadiationTherapy, Internal Beam Radiation Therapy
Key market players worldwideSiemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay


Other key industry trends

  • In terms of revenue, Europe region accounted for 26.5% of the global radiation oncology market in 2020.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2028.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 2,803.8 million by 2028.

External beam radiationtherapy was the largest segment with a revenue share of 68.41% in 2020. Horizon Databook has segmented the Europe radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.


Europe is a major contributor to revenue of global radiation oncology market. Presence of sophisticated technology, well-established research infrastructure, and rise in government initiatives are some of the major factors responsible for the growth of this market in Europe. 

In June 2017, The European government spent GBP 250 million to develop two NHS centers providing proton beam therapy at The Christie Hospital, Manchester. Rising awareness among cancer patients about radiation oncology treatment is expected to boost the market. 

For instance, Gustave Roussy the premier European Cancer Center provides an integrated approach to patient care, education, and research to benefit patients with best quality treatment such as chemotherapy and radiation therapy.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Radiation Oncology Market Companies

Name Profile # Employees HQ Website

Europe radiation oncology market size, by country, 2017-2028 (US$M)

Europe Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)

Europe radiation oncology market size, by country, 2017-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more